false
OasisLMS
Catalog
The Liver Meeting 2023
3066 Cirrhosis As a Multisystem Disorder - Part 2
3066 Cirrhosis As a Multisystem Disorder - Part 2
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In the video, Dr. Rohit Lumba discussed emerging therapeutics for patients with cirrhosis, focusing on the need to prevent mortality related to the disease. He emphasized the importance of precision-based approaches and clinical development of drugs for NASH cirrhosis. Dr. Perra Ghiness highlighted the need for a holistic and multidisciplinary approach in cirrhosis care, addressing the high mortality and morbidity associated with the disease. Discussions included strategies for early diagnosis, personalized therapy, and better management of the etiology of cirrhosis. The speakers also touched on the importance of frailty assessment, patient support, and addressing the stigma surrounding cirrhosis care. The session concluded with suggestions for improving quality of life for cirrhosis patients who may not be eligible for liver transplantation, emphasizing the need for ongoing support and holistic care.
Keywords
cirrhosis
therapeutics
mortality prevention
precision-based approaches
NASH cirrhosis
multidisciplinary care
early diagnosis
frailty assessment
quality of life improvement
×
Please select your language
1
English